Related Experiment Videos
Lymphoscintigraphy in vulvar cancer: a pilot study
D P Barton1, C Berman, D Cavanagh
1Division of Gynecologic Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida 33612-9497.
Gynecologic Oncology
|September 1, 1992
Summary
Vulvar lymphoscintigraphy using Technetium-antimony trisulfide colloid (Tc 99m ASC) did not predict metastatic nodal disease in vulvar cancer patients. Further research is needed to establish its role in managing this condition.
Area of Science:
- Oncology
- Nuclear Medicine
- Surgical Pathology
Background:
- Vulvar cancer management requires accurate assessment of inguino-femoral lymph node status.
- Lymphatic drainage patterns are crucial for staging and treatment planning.
Purpose of the Study:
- To correlate vulvar lymphoscintigraphy findings with clinical and pathological lymph node status in vulvar cancer patients.
- To evaluate the predictive value of Technetium-antimony trisulfide colloid (Tc 99m ASC) uptake patterns for metastatic nodal disease.
Main Methods:
- Pilot study involving ten patients with vulvar cancer.
- Perilesional injection of Tc 99m ASC radionuclide.
- Post-injection imaging at 2-4 hours to assess lymphatic drainage patterns.
Main Results:
- Lymphoscintigraphy uptake patterns (unilateral vs. bilateral) did not consistently predict the presence or side of metastatic nodal disease.
- Three patients with suspicious bilateral groin nodes had metastatic disease, with variable lymphoscintigraphy uptake.
- Three patients undergoing bilateral lymphadenectomy for unilateral lesions had no metastasis.
Conclusions:
- The pattern of Tc 99m ASC uptake in vulvar lymphoscintigraphy was not predictive of metastatic nodal disease.
- Lymphoscintigraphy may show concordance with recurrence patterns in some cases but requires further investigation.
- Additional data are necessary to define the definitive role of lymphoscintigraphy in the management of vulvar cancer.